# ReNetX Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/renetx-bio

- Industry: Biotechnology
- Headquarters: New Haven, US
- Website: www.renetx.com
- Total disclosed funding: $1.7M
- Latest round: Series A (Apr 6, 2018)
- Investors on record: 2

## About

Founded in 2010 and based in Connecticut, US, ReNetX Bio, Inc. is a biotechnology that operates as a developer of treatments focusing on injury and damage of the central nervous system such as spinal cord injury, stroke, and glaucoma.

## Funding rounds

- Series A, Apr 6, 2018, $1.7M — Connecticut Innovations, Spring Mountain Capital

## Investors

- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A
- Spring Mountain Capital (https://capitalatlas.ai/funds/spring-mountain-capital) — Series A